Agents in Development for Anxiety Disorders
- 1 June 2000
- journal article
- Published by Springer Nature in CNS Drugs
- Vol. 13 (6) , 421-431
- https://doi.org/10.2165/00023210-200013060-00004
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Plasma Neuropeptide Y (NPY) Increases in Humans in Response to the α2 Antagonist YohimbineNeuropsychopharmacology, 1998
- Serotonergic‘vulnerability’ in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram‐respondersActa Psychiatrica Scandinavica, 1998
- Gepirone and Diazepam in Generalized Anxiety DisorderJournal of Clinical Psychopharmacology, 1997
- Cholecystokinin in anxietyEuropean Neuropsychopharmacology, 1996
- The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorderEuropean Neuropsychopharmacology, 1996
- Serotonin, Psilocybin, and Body Dysmorphic DisorderJournal of Clinical Psychopharmacology, 1996
- Inositol treatment of post-traumatic stress disorderAnxiety, 1996
- Role of the amygdala and periaqueductal gray in anxiety and panicBehavioural Brain Research, 1993
- Effect of a Serotonin Precursor and Uptake Inhibitor in Anxiety Disorders; a Double-Blind Comparison of 5-Hydroxytryptophan, Clomipramine and PlaceboInternational Clinical Psychopharmacology, 1987
- Behavioral inhibition induced by electrical stimulation of the median raphe nucleus of the ratPhysiology & Behavior, 1978